Ascorbic Acid and Cytochrome P-450
Overview
Authors
Affiliations
Liver microsomal cytochrome P-450 is significantly reduced in ascorbic acid-deficient guinea pigs and studies are presented on the biochemical basis for this effect. The activities of the key enzymes involved in heme synthesis, delta-aminolevulinic acid (ALA) synthetase. ALA dehydratase and ferrochelatase, were not significantly reduced in livers from ascorbic acid-deficient animals. In addition, there was no significant difference in the amount of "mitochondrial heme" in normal and ascorbic acid-deficient livers. However, ascorbic acid deficiency did affect induction with diethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate; a 6-fold increase in ALA synthetase activity occurred in liver homogenates prepared from normal animals in contrast to no significant increase in homogenates prepared from ascorbic acid-deficient animals. Multiple forms of cytochrome P-450 exist in guinea-pig microsomes as has been demonstrated in microsomes from other species. Separation of 44,000 to 60,000 dalton polypeptides (molecular weight region for the various forms of cytochrome P-450) by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate revealed quantitative differences in the polypeptides from normal and ascorbic acid-deficient microsomes. Ascorbic acid-deficient microsomes consistently demonstrated reductions in three polypeptide bands (molecular weight 44,000, 52,000 and 57,000) and increases in two polypeptide bands (54,000 and 55,000) compared with normal microsomes. Evidence that these polypeptides are cytochrome P-450 was obtained from heme staining with tetramethylbenzidine and from induction studies with phenobarbital and 3-methylcholanthrene. The results indicate that ascorbic acid deficiency does not affect the availability of heme for cytochrome P-450 synthesis and the effect of ascorbic acid may be on the apoprotein moiety of cytochrome P-450.
Siritientong T, Thet D, Methaneethorn J, Leelakanok N Nutrients. 2022; 14(3).
PMID: 35276881 PMC: 8840371. DOI: 10.3390/nu14030520.
Ikewuchi J, Ikewuchi C, Igboh N, Mark-Balm T EXCLI J. 2017; 10:312-321.
PMID: 29033712 PMC: 5611610.
Ikewuchi J, Uwakwe A, Onyeike E, Ikewuchi C EXCLI J. 2017; 10:280-289.
PMID: 29033709 PMC: 5611619.
Vitamin C-status and pharmacokinetic profile of antipyrine in man.
Ginter E, VEJMOLOVA J Br J Clin Pharmacol. 1981; 12(2):256-8.
PMID: 7306442 PMC: 1401859. DOI: 10.1111/j.1365-2125.1981.tb01213.x.
Miyauchi M, Uematsu T Bull Environ Contam Toxicol. 1990; 45(3):422-9.
PMID: 2257338 DOI: 10.1007/BF01701167.